An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: Relevance to its use as a model of the CYP2d6 poor metaboliser phenotype-Reference-Cited by-同舟云学术

An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: Relevance to its use as a model of the CYP2d6 poor metaboliser phenotype

Published:1994-04 Issue:8 Volume:47 Page:1295-1307
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Barham H.M.,Lennard M.S.,Tucker G.T.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference70 articles.

1. The genetic polymorphism of debrisoquine/sparteine metabolism: clinical aspects;Eichelbaum;Pharmacol Ther,1990

2. Antibodies against human cytochrome P450db1 in autoimmune hepatitis type II;Zanger,1988

3. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes;Otton;J Pharmacol Exp Ther,1988

4. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation;Islam;Carcinogenesis,1991

5. Meuldermans W and Donne-Op den Kelder GM, A predictive model for substrates of cytochrome P450-debrisoquine (2D6);Koymans;Chem Res Toxicol,1992

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague–Dawley and Dark Agouti rats;Xenobiotica;2014-07-22

2. Environmentally persistent free radicals inhibit cytochrome P450 activity in rat liver microsomes;Toxicology and Applied Pharmacology;2014-06

3. Effects of physiological and biochemical factors based on aging, pathological conditions and drug combinations on propranolol pharmacokinetics using physiologically-based pharmacokinetic model in humans;Biomedicine & Aging Pathology;2013-07

4. Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation;FEBS Letters;2012-05-25

5. Two Faces of 1,2,3,4-Tetrahydroisoquinoline Mode of Action in the Mammalian Brain: Is It an Endogenous Neurotoxin or a Neuromodulator?;Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants;2011-11-10